Skip to main content
. 2024 Apr 12;75:103730. doi: 10.1016/j.breast.2024.103730

Table 2.

Treatment characteristics.

Systemic treatment at MBC diagnosis (within 2 months)
Yes 60 (86%)
No 10 (14%)
Metastasis directed treatment at MBC diagnosis (within 2 months)
Surgery 12 (17%)
SABR 6 (9%)
Non-stereotactic radiotherapy 17 (24%)
None 37 (53%)
Metastasis directed treatment at any time
Surgery 18 (26%)
SABR 15 (21%)
Non-stereotactic radiotherapy 33 (47%)
None 12 (17%)